CEO Circles
Confidential, member-led, 3-month circles for healthcare and healthtech CEOs working through the operating decisions behind AI adoption. Two circles, each limited to 6 to 8 peers and curated for relevance, stage, and the decisions members are actively facing.
Same model, curated for two different sets of operating decisions.
For CEOs deciding where AI should change operations, margin, quality, capacity, staffing, and patient experience, without vendor sprawl or disconnected pilots.
Explore this circleFor CEOs bringing AI-enabled products to market that have to survive buyer, investor, enterprise, and regulatory scrutiny, and convert pilots into contracts.
Explore this circleThis is not a course, class, or generic AI curriculum. The circle is shaped by the live operating questions CEOs bring into the room. Before each session, members share the decisions they are working through. Arvita uses those inputs to shape a focused prompt and select one or two member cases for deeper peer discussion.
Between live sessions, members receive one short prompt to surface the decisions, questions, or patterns showing up in their companies. It helps shape the next discussion without adding another meeting.
The value of the circle depends on who is in it. This is not open enrollment. Before confirming a group, Arvita reviews fit across:
The goal is not to make every company identical. It is to put CEOs in a room with peers working at a comparable level of complexity. If the room is not likely to be useful, Arvita will say so.
The circle gives you a curated peer room and access to Arvita's framing, prompts, and pattern recognition. Direct advisory is specific to your company: your operating model, AI roadmap, governance, workflows, board questions, vendor strategy, or market strategy. Some members only need the circle. Others use it to identify where deeper advisory support would help.
The room is curated before anyone is confirmed. Members are selected for relevance, seniority, stage fit, AI maturity, and the decisions they are actively facing. Each session is built around live CEO questions, not generic content.
That is exactly what curation is designed to avoid. The goal is not identical companies. It is comparable operating complexity. A company exploring its first AI use case and a company scaling AI across multiple business lines may not belong in the same room.
Competitive sensitivity is considered before confirming a circle. If a conflict would make the room less candid or useful, it is addressed upfront.
Yes. Members are expected not to attribute comments, company details, or sensitive operating issues outside the group. Arvita may share anonymized themes or patterns in writing or talks, but not identifiable company information or member-specific details without permission.
No. The circle is member-led, expert-framed, and peer-tested. Arvita opens with a short prompt, but the substance comes from the live decisions members bring into the room.
No, not as members. This is not a pitch room.
Members can choose whether to continue, join a more focused circle, attend future private sessions, or explore advisory support. There is no obligation.
Arvita Tripati advises healthcare, healthtech, medtech, diagnostics, life sciences, and tech-enabled services leaders on AI operating models, regulated product strategy, market readiness, and adoption. Her work connects product judgment, governance, workflow adoption, claims, evidence, commercial value, and operating reality. She is the founder of Vahana Labs and the author of the forthcoming book Built to Survive.
If you are a CEO working through where AI should change the business, request an invitation or ask about fit.